tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ADAG Stock Latest News

Adagene files to sell 10.625M ordinary shares or 8.5M ADSs for holders
The FlyAdagene files to sell 10.625M ordinary shares or 8.5M ADSs for holders
4d ago
ADAG
Adagene says first patient dosed in Phase 2 study of muzastotug, KEYTRUDA
PremiumThe Fly
Adagene says first patient dosed in Phase 2 study of muzastotug, KEYTRUDA
4d ago
MRK
ADAG
Tempest Therapeutics and Adagene’s Promising Advances in Liver Cancer Treatment
PremiumCompany Announcements
Tempest Therapeutics and Adagene’s Promising Advances in Liver Cancer Treatment
8d ago
ADAG
TPST
Adagene’s Innovative Cancer Study: A Potential Game-Changer in Oncology
PremiumCompany Announcements
Adagene’s Innovative Cancer Study: A Potential Game-Changer in Oncology
8d ago
ADAG
Adagene initiated with a Buy at Lucid Capital
PremiumThe Fly
Adagene initiated with a Buy at Lucid Capital
2M ago
ADAG
Adagene expands SAFEbody collaboration, license agreement with Exelixis
PremiumThe FlyAdagene expands SAFEbody collaboration, license agreement with Exelixis
2M ago
ADAG
Adagene appoints Hoos as Executive Advisor
Premium
The Fly
Adagene appoints Hoos as Executive Advisor
2M ago
ADAG
Adagene’s Promising Position in Next-Gen CTLA-4 Class: Buy Rating Reinforced by Clinical Success and Strategic Optionality
Premium
Ratings
Adagene’s Promising Position in Next-Gen CTLA-4 Class: Buy Rating Reinforced by Clinical Success and Strategic Optionality
3M ago
ADAG
Adagene’s Strategic Partnerships and Regulatory Milestones Drive Buy Rating
PremiumRatings
Adagene’s Strategic Partnerships and Regulatory Milestones Drive Buy Rating
3M ago
ADAG
Adagene price target lowered to $7 from $8 at H.C. Wainwright
PremiumThe Fly
Adagene price target lowered to $7 from $8 at H.C. Wainwright
3M ago
ADAG
Adagene Announces H1 2025 Financial Results and Strategic Developments
PremiumCompany Announcements
Adagene Announces H1 2025 Financial Results and Strategic Developments
3M ago
6K
ADAG
Adagene initiated with an Outperform at Leerink
PremiumThe Fly
Adagene initiated with an Outperform at Leerink
3M ago
ADAG
Adagene Advances Clinical Plan for ADG126 in Colorectal Cancer After FDA Meeting
PremiumCompany AnnouncementsAdagene Advances Clinical Plan for ADG126 in Colorectal Cancer After FDA Meeting
4M ago
6K
ADAG
Adagene announces regulatory update on development plan for muzastotug
Premium
The Fly
Adagene announces regulatory update on development plan for muzastotug
4M ago
MRK
ADAG
Adagene and ConjugateBio partner to develop antibody drug conjugate
Premium
The Fly
Adagene and ConjugateBio partner to develop antibody drug conjugate
4M ago
ADAG
Adagene Secures $25 Million Investment from Sanofi to Advance Cancer Therapies
PremiumCompany Announcements
Adagene Secures $25 Million Investment from Sanofi to Advance Cancer Therapies
4M ago
6K
ADAG
Adagene announces up to $25M strategic investment from Sanofi
PremiumThe Fly
Adagene announces up to $25M strategic investment from Sanofi
4M ago
SNY
ADAG
Adagene Reports Promising ADG126 Study Results at ASCO
PremiumCompany Announcements
Adagene Reports Promising ADG126 Study Results at ASCO
6M ago
6K
ADAG
Adagene files $200M mixed securities shelf
PremiumThe Fly
Adagene files $200M mixed securities shelf
6M ago
ADAG
Adagene appoints John Maraganore as Executive Advisor
PremiumThe FlyAdagene appoints John Maraganore as Executive Advisor
6M ago
ADAG
Adagene’s Promising Clinical Developments and Strong Financial Outlook Justify Buy Rating
Premium
Ratings
Adagene’s Promising Clinical Developments and Strong Financial Outlook Justify Buy Rating
7M ago
ADAG
Adagene Inc. Reports 2024 Financial Results and Progress
Premium
Company Announcements
Adagene Inc. Reports 2024 Financial Results and Progress
7M ago
ADAG

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >